Latest Insider Transactions at Candel Therapeutics, Inc. (CADL)
This section provides a real-time view of insider transactions for Candel Therapeutics, Inc. (CADL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Candel Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Candel Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 21
2024
|
Paul Peter Tak Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,900
+3.62%
|
$12,900
$1.55 P/Share
|
|
Nov 08
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.89%
|
$30,000
$4.92 P/Share
|
|
Nov 08
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.85%
|
$30,000
$4.92 P/Share
|
|
Nov 07
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.89%
|
$37,500
$5.19 P/Share
|
|
Nov 07
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.84%
|
$37,500
$5.19 P/Share
|
|
Nov 06
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.88%
|
$37,500
$5.33 P/Share
|
|
Nov 06
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.84%
|
$37,500
$5.33 P/Share
|
|
Nov 01
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.87%
|
$37,500
$5.27 P/Share
|
|
Nov 01
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.83%
|
$37,500
$5.27 P/Share
|
|
Oct 31
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
7,500
-0.86%
|
$37,500
$5.3 P/Share
|
|
Oct 31
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,500
-0.82%
|
$37,500
$5.3 P/Share
|
|
Oct 30
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
6,000
-0.69%
|
$30,000
$5.38 P/Share
|
|
Oct 30
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,000
-0.65%
|
$30,000
$5.38 P/Share
|
|
Oct 28
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
11,711
-1.3%
|
$58,555
$5.58 P/Share
|
|
Oct 25
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,597
-0.18%
|
$7,985
$5.8 P/Share
|
|
Oct 24
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,621
-0.96%
|
$88,105
$5.63 P/Share
|
|
Oct 15
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,412
-1.12%
|
$62,472
$6.03 P/Share
|
|
Oct 14
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,000
-1.59%
|
$90,000
$6.02 P/Share
|
|
Oct 11
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,000
-1.56%
|
$90,000
$6.05 P/Share
|
|
Oct 03
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,800
-0.19%
|
$10,800
$6.85 P/Share
|
|
Oct 02
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
26,988
-2.73%
|
$161,928
$6.92 P/Share
|
|
Oct 01
2024
|
Estuardo Aguilar Cordova > 10% Shareholder |
BUY
Open market or private sale
|
Direct |
6,214
+0.62%
|
$43,498
$7.01 P/Share
|
|
Jul 17
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
22,528
-6.38%
|
$135,168
$6.47 P/Share
|
|
Jul 17
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
14,851
-9.23%
|
$89,106
$6.47 P/Share
|
|
Jul 17
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
14,051
-8.07%
|
$84,306
$6.47 P/Share
|
|
Jul 17
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,875
-8.68%
|
$65,250
$6.47 P/Share
|
|
Jul 17
2024
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
9,884
-13.65%
|
$59,304
$6.47 P/Share
|
|
Jul 11
2024
|
Paul Peter Tak Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
20,293
-5.43%
|
$101,465
$5.97 P/Share
|
|
Jul 11
2024
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
13,330
-7.65%
|
$66,650
$5.97 P/Share
|
|
Jul 11
2024
|
Francesca Barone Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
12,645
-6.77%
|
$63,225
$5.97 P/Share
|
|
Jul 11
2024
|
William Garrett Nichols Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,769
-7.23%
|
$48,845
$5.97 P/Share
|
|
Jul 11
2024
|
Charles Schoch |
SELL
Open market or private sale
|
Direct |
8,897
-10.94%
|
$44,485
$5.97 P/Share
|
|
Nov 28
2023
|
Jason Amello Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
20,153
-9.07%
|
$0
$0.9 P/Share
|
|
Nov 28
2023
|
Francesca Barone Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
19,748
-9.57%
|
$0
$0.9 P/Share
|
|
Nov 28
2023
|
William Garrett Nichols Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
12,175
-8.27%
|
$0
$0.9 P/Share
|
|
Nov 28
2023
|
Paul Peter Tak Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
43,443
-10.42%
|
$0
$0.9 P/Share
|
|
Nov 28
2023
|
Seshu Tyagarajan Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,328
-9.05%
|
$0
$0.9 P/Share
|
|
Nov 26
2023
|
Jason Amello Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
125,717
+36.14%
|
-
|
|
Nov 26
2023
|
Francesca Barone Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
112,790
+35.34%
|
-
|
|
Nov 26
2023
|
William Garrett Nichols Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
88,822
+37.62%
|
-
|
|
Nov 26
2023
|
Seshu Tyagarajan Chief Technology Officer |
BUY
Grant, award, or other acquisition
|
Direct |
104,516
+35.3%
|
-
|
|
Nov 26
2023
|
Paul Peter Tak Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
180,108
+30.16%
|
-
|
|
Dec 09
2022
|
Joseph C Papa |
BUY
Open market or private purchase
|
Direct |
35,018
+47.94%
|
$35,018
$1.94 P/Share
|
|
Dec 09
2022
|
Christopher Martell |
BUY
Open market or private purchase
|
Direct |
23,950
+13.61%
|
$23,950
$1.92 P/Share
|
|
Dec 09
2022
|
Seshu Tyagarajan Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
10,358
+43.68%
|
$10,358
$1.93 P/Share
|
|
Dec 09
2022
|
Paul Peter Tak Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
12,935
+23.99%
|
$12,935
$1.92 P/Share
|
|
Dec 09
2022
|
Jason Amello Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,468
+30.71%
|
$2,468
$1.93 P/Share
|
|
Dec 08
2022
|
Joseph C Papa |
BUY
Open market or private purchase
|
Direct |
3,014
+50.0%
|
$3,014
$1.7 P/Share
|
|
Dec 08
2022
|
Christopher Martell |
BUY
Open market or private purchase
|
Direct |
3,050
+2.33%
|
$3,050
$1.68 P/Share
|
|
Dec 08
2022
|
Seshu Tyagarajan Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
3,000
+50.0%
|
$3,000
$1.69 P/Share
|